DrugDashboards

Cefazolin

Cefazolin · CEFAZOLIN SODIUM 3 g/1 · Injection, Powder, For Solution · Intravenous · Hikma Pharmaceuticals USA Inc.

NDC 00143-9140-25 · 25 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL · NDA · View full market →

The short version

13 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.4% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$219.38
Reported to Texas DSHS · 2026 annual filing · Hikma Pharmaceuticals USA Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 500 MG
$0.847
HCPCS J0688 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$9,255
1,526 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.4%chance of a new FDA shortage posting for cefazolin (injectable) in the next 90 days

sterile injectable · sole-source market · price up 6% YoY

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA216109
TE code
—
Approval date
Oct 7, 2022
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Cefazolin (Injection, Powder, For Solution)

LabelerStrengthFirst seenLast seen
Apotex Corp.CEFAZOLIN SODIUM 10 g/1Jul 15, 2026Sep 3, 2026
Apotex Corp.CEFAZOLIN SODIUM 1 g/1Jul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.CEFAZOLIN SODIUM 10 g/1Jul 15, 2026Sep 3, 2026
WG Critical Care, LLCCEFAZOLIN SODIUM 1 g/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsCEFAZOLIN SODIUM 330 mg/mLJul 15, 2026Sep 2, 2026
Apotex Corp.CEFAZOLIN SODIUM 2 g/1Jul 15, 2026Sep 2, 2026
Apotex Corp.CEFAZOLIN SODIUM 3 g/1Jul 15, 2026Sep 2, 2026
Civica, Inc.CEFAZOLIN SODIUM 2 g/1Aug 26, 2026Sep 2, 2026
Civica, Inc.CEFAZOLIN SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
Civica, Inc.CEFAZOLIN SODIUM 10 g/1Jul 15, 2026Sep 2, 2026
Henry Schein Inc.CEFAZOLIN SODIUM 225 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.CEFAZOLIN SODIUM 330 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.CEFAZOLIN SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CEFAZOLIN SODIUM 2 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CEFAZOLIN SODIUM 3 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CEFAZOLIN SODIUM 225 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CEFAZOLIN SODIUM 20 g/1Jul 15, 2026Sep 2, 2026
Hospira, IncCEFAZOLIN SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCCEFAZOLIN SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCCEFAZOLIN SODIUM 330 mg/mLJul 15, 2026Sep 2, 2026
Proficient Rx LPCEFAZOLIN SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
ProPharma DistributionCEFAZOLIN SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
Qilu Pharmaceutical Co., Ltd.CEFAZOLIN SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
Sandoz IncCEFAZOLIN SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
Sandoz IncCEFAZOLIN SODIUM 10 g/1Jul 15, 2026Sep 2, 2026
WG Critical Care, LLCCEFAZOLIN SODIUM 2 g/1Jul 15, 2026Sep 2, 2026
WG Critical Care, LLCCEFAZOLIN SODIUM 10 g/1Jul 15, 2026Sep 2, 2026
WG Critical Care, LLCCEFAZOLIN SODIUM 500 mg/1Jul 15, 2026Sep 2, 2026
WG Critical Care, LLCCEFAZOLIN SODIUM 3 g/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CEFAZOLIN SODIUM 330 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Cefazolin — NDC 00143-9140-25," retrieved September 3, 2026, https://drugdashboards.com/drug/00143914025.

Free to cite with attribution — see how the data is put together.